Developing Communications That Deliver a Product’s Value Story to Payers, Providers, and Patients

HEOR/RWE MEDICAL COMMUNICATIONS AGENCY

Our expertise in HEOR/RWE value communications enables our clients to engage our team across a full spectrum of medical communications support. We integrate your payer and provider communication strategies.

We develop communications that effectively deliver your product’s clinical and economic value story.

HEOR/RWE MEDICAL WRITING & EDITING SERVICES

  • Abstracts, posters, manuscripts, review articles
  • Dossiers: Academy of Managed Care Pharmacy (AMCP) dossiers, global value dossiers (GVDs), patient-reported outcomes (PRO) dossiers
  • Slide presentations
  • Literature summaries
  • Newsletters
  • Product monographs /white papers

STRATEGIC PUBLICATION PLANNING

  • Literature reviews
  • Competitive landscape reports
  • Gap analyses
  • Scientific message platforms
  • Product lexicons
  • Publication plans

Responsive-web-developmentDIGITAL AND WEB COMMUNICATIONS

  • Web development —websites, microsites, content
  • Enhanced manuscripts and posters
  • Digital libraries/resource centers
  • E-newsletters
  • Field-based content and training materials

HEOR data analysisDATA ANALYTIC & BIOSTATISTICS SERVICES

Experienced and Scalable HEOR/Biopharma Analytics Team

Payers do not currently have a standardized process for requesting or for using HEOR/RWE data. There is a lack of standardization regarding how such information is integrated into the current processes for drug (and other technology) evaluations. We will work with you to customize your analysis output to meet specific stakeholder’s information needs.

interactive digital libraryHEOR DATA IN HEALTHCARE DECISION-MAKING

Health Economics and Outcomes Research (HEOR) complements clinical development, helping decision makers and healthcare payers determine patient access to specific drugs, services, and reimbursement policies – READ ARTICLE

 

 

  • Health Care system research
  • Health Economics models adaptation
    – modeling, prospective, retrospective and quality of life studies.
  • HTA submission documents
  • Market Access materials development (communications for payers)
  • Payers primary & secondary research
  • Real-World Evidence – Meta-analysis and policy analysis
  • Systematic literature reviews
  • Value dossiers construction